MTOR and glioblastoma: Another pharmacological blockade using mibefradil and siRNA-mediated knockdown of T-type VGCC reduces cell survival and induces apoptosis through the mTOR/Akt pathway in GBM (Valerie et al., 2013) and GBM stem-like cells (Zhang et al., 2017).